Acadia Pharmaceuticals Inc.
Clinical trials sponsored by Acadia Pharmaceuticals Inc., explained in plain language.
-
New drug trial targets terrifying hallucinations in Alzheimer's patients
Disease control Recruiting nowThis research tests whether the experimental drug ACP-204 can reduce distressing hallucinations and delusions in people with Alzheimer's disease. The study involves over 1,000 adults aged 55-95 who experience these psychotic symptoms. Participants will receive either the drug or …
Phase: PHASE2, PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for Treatment-Resistant depression: experimental drug trial seeks participants
Disease control Recruiting nowThis study is testing whether an experimental drug called ACP-211 can help adults with major depression who haven't gotten better with standard antidepressant treatments. Researchers will compare ACP-211 against a placebo (inactive pill) to see if it reduces depression symptoms m…
Phase: PHASE2 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New hope for dementia patients: experimental drug targets troubling psychosis symptoms
Symptom relief Recruiting nowThis study is testing whether an experimental medication called ACP-204 can help reduce psychosis symptoms in people with Lewy body dementia. About 180 adults aged 55-85 with this condition will receive either the actual medication or a placebo for 6 weeks. Researchers will measu…
Phase: PHASE2 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC